Altre lingue Recursion Pharmaceuticals, Inc.

Azioni

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 26/04/2024			Variaz. 5gg	Var. 1 gen.
8,12 ^USD	+3,57%		+6,84%	-17,65%

18/04	L'insider di Recursion Pharmaceuticals ha venduto azioni per un valore di 367.007 dollari, secondo un recente documento SEC	MT
16/04	Recursion nomina Najat Khan come Chief R&D Officer e Chief Commercial Officer	CI

Recursion Pharmaceuticals Insider Sold Shares Worth $367,007, According to a Recent SEC Filing	18/04
Recursion Pharmaceuticals Names Najat Khan Chief R&D Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion Appoints Najat Khan as Chief R&D Officer and Chief Commercial Officer	16/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion to Participate in Upcoming Investor Conference	02/04
Recursion Publishes Annual Environmental, Social and Governance Report	26/03
50 valores para invertir en IA, salud, movilidad y energía	25/03
50 aandelen om te beleggen in KI, gezondheid, mobiliteit en energie	23/03
50 Top-Aktien für Investitionen in KI, Gesundheit, Mobilität und Energie	22/03
50 valeurs pour investir dans l'IA, la Santé, la Mobilité et l'Energie	22/03
Recursion Pharmaceuticals Insider Sold Shares Worth $537,190, According to a Recent SEC Filing	15/03
Recursion Pharmaceuticals to Open London Office	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Announces Plans to Open New Office in London	11/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03
Recursion to Participate in Upcoming Investor Conferences	01/03

Non ci sono risultati per questa ricerca